Villar, J. C. (2019). Correction to: Nifurtimox versus benznidazole or placebo for asymptomatic Trypanosoma cruzi infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): study protocol for a randomised controlled trial (Trials DOI: 10.1186/s13063-019-3423-3). BioMed Central Ltd.
Citación estilo ChicagoVillar, Juan Carlos. Correction To: Nifurtimox Versus Benznidazole or Placebo for Asymptomatic Trypanosoma Cruzi Infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study Protocol for a Randomised Controlled Trial (Trials DOI: 10.1186/s13063-019-3423-3). BioMed Central Ltd, 2019.
Cita MLAVillar, Juan Carlos. Correction To: Nifurtimox Versus Benznidazole or Placebo for Asymptomatic Trypanosoma Cruzi Infection (Equivalence of Usual Interventions for Trypanosomiasis - EQUITY): Study Protocol for a Randomised Controlled Trial (Trials DOI: 10.1186/s13063-019-3423-3). BioMed Central Ltd, 2019.